share_log

Nautilus Biotechnology's Cash, Cash Equivalents, And Investments Were $247.7M As Of March 31, 2024

Benzinga ·  Apr 30 19:06
Nautilus Biotechnology's Cash, Cash Equivalents, And Investments Were $247.7M As Of March 31, 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment